Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07426952 · ClinicalTrials.gov registry record · NA

Weight Management After Cancer for Survivors in Rural Communities

A NA study of Breast Cancer and Weight Management, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
3
Study locations

NCT07426952: Recruiting NA study of Breast Cancer and Weight Management, sponsored by Duke University.

NCT07426952 is a NA study of Breast Cancer and Weight Management that is actively recruiting participants, run by Duke University. The registered enrollment target is 40 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07426952, a NA study of Breast Cancer and Weight Management, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
3
Study locations

Study Summary

This study is testing a new program called WeCan-Rural, designed to help breast cancer survivors manage symptoms and build healthy habits like eating well, staying active, and managing their weight. These changes may help lower the risk of heart disease after cancer treatment. The study will answer two main questions: * Can we successfully recruit and keep participants in the study, and will they find the program helpful and easy to follow? * Will people who join the program see better results in areas like weight, symptoms, diet, physical activity, and confidence in managing their health compared to those who receive standard care? Here's what participants will do: * Visit their clinic twice (about 12 weeks apart) to be weighed, have their blood pressure checked, give a blood sample, and complete a short walking test * Fill out online surveys about their health, diet, physical activity, symptoms, and confidence in managing their health * Be randomly assigned (like flipping a coin) to either receive the WeCan-Rural program or standard health information * If assigned to the program, attend 12 weekly one-hour video sessions on Zoom with a trained therapist

Primary Outcome

Participants will complete the 13-item Satisfaction with Therapy and Therapist Scale-Revised specific to the program they received. The first 12 items ask participants to rate their agreement with statements related to intervention satisfaction on a 5-point scale ranging from "strongly disagree" (1) to "strongly agree" (5). The 13th item asks "How much did the intervention help with your symptoms?" with 5 answer choices ranging from "made things a lot better" to "made things a lot worse."

Interventions

  • BEHAVIORAL WeCan-Rural Program

Study Locations (3)

North Carolina

  • Maria Parham Cancer Center - Henderson
  • Scotland Health - Laurinburg
  • UNC Health Southeastern - Lumberton

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-01-13
Est. Completion 2026-12-31
Phase NA
Duke University

1,725 total trials

What NCT07426952 shows while recruiting

NCT07426952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which WeCan-Rural Program is the first listed.

NCT07426952 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07426952 about?

NCT07426952 is a clinical study titled "Weight Management After Cancer for Survivors in Rural Communities". This study is testing a new program called WeCan-Rural, designed to help breast cancer survivors manage symptoms and build healthy habits like eating well, staying active, and managing their weight. These changes may help lower the risk of heart disease after cancer treatment. The study will answer...

What is the current status of trial NCT07426952?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-01-13. Estimated completion is 2026-12-31.

What conditions does trial NCT07426952 study?

This clinical trial studies the following conditions: Breast Cancer, Weight Management, Cardiovascular (CV) Risk, Breast Cancer Survivorship.

What interventions are being tested in trial NCT07426952?

The interventions under investigation include: WeCan-Rural Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT07426952?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07426952 being conducted?

This trial has 3 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07426952's enrollment target sits among peer trials

40 876th of 1224 higher than 325 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07426952, the US trial registry maintained by the National Library of Medicine. NCT07426952 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.